The upregulated expression of TLR3 was associated with sensitivity of cancer cells to erdafitinib (JNJ-42756493) and duvelisib (IPI-45), but it was associated with increased drug resistance to tyrothricin. The gene discussed is TLR3; the disease is cancer.